All tags Custom Services Custom Services testimonials

Custom Services testimonials

Providing the best possible service and highest quality antibodies is a top priority at Abcam.

We believe that by sharing some of our customer's success stories, we can inform and inspire other researchers who could benefit from our custom antibody development.



"In the last 6 years we have developed a number of very useful rabbit monoclonal antibodies. For our research work such sensitive and specific tools had not been available before.

Without the project planning and management of the group in Vienna and without the excellent scientists in California this success story would not have been possible."

Dr. Pidder Jansen-Duerr, Institute for Biomedical Ageing Research of the Austrian Academy of Sciences 


Dr. V. Lindner, Maine Medical Center Research Institute


Q: Did your custom RabMAb® primary antibody meet your expectations?

A: Absolutely, yes.

Q: Describe the performance/effectiveness of the custom RabMAb primary antibody you developed with us.

A: Outstanding, much better than any commercially available ones.


Resulting publications


Dr. Lucia Tapia, University of British Columbia

Q: Did your custom RabMAb primary antibody meet your expectations?

A: Absolutely. The process is not finished yet but at the final phase. It has been within the proposed times and the communication with Liyu, our project manager, has been excellent.

Q: Describe the performance/effectiveness of the custom RabMAb primary antibody you developed with us.

A: The antibody so far shows to be highly specific and high titer. We are very pleased with it. We have tried it in western blot and ICC.


Dr. Pankaj d. Mehta, Institute for Basic Research (IBR)

Q: Did your custom RabMAb primary antibody meet your expectations?

A: Yes. They were highly specific to an immunogenicity.

Q: Describe the performance/effectiveness of the custom RabMAb primary antibody you developed with us.

A: Excellent. RabMAb with high affinity.

Q: How would you describe the service you received for your custom antibody development project?

A: Lab staff is very cooperative, and efficient.

Resulting publications

High-Affinity Rabbit Monoclonal Antibodies Specific for Amyloid Peptides Amyloid-β40 and Amyloid-β42. Miller, D.L., et al. (2011), Journal of Alzheimer’s Disease 23: 293-305.


Dr. Kathleen Worringer, Gladstone Institutes

Q: Describe the performance/effectiveness of the custom RabMAb primary antibody you developed with us.

A: The RabMAb has good performance so far. It identifies the target protein in assays tested so far: western blotting and immunofluorescence. We are just beginning to test it for functionality for immunoprecipitation.